Please upgrade your browser.
One of the tragi-comic sideshows of passing ObamaCare was the Democratic attempt to buy off the American Medical Association . . .
Axitinib significantly extended progression-free survival
"These data, in addition to positive tivozanib Phase 2 monotherapy data in patients with advanced kidney cancer, indicate significant potential for tivozanib across multiple tumor types.
If the Centers for Medicare and Medicaid Service and the Food and Drug Administration and god knows what other panels lurking in the lost crevices of our sprawling government decide to block access to Provenge, if they block Avastin, if they block Sutent, who will spend the billions necessary to research, develop, and bring new drugs to market?
To have the best chance of quitting successfully, you need to know what you're up against, what your options are, and where to go for help.
In an open label trial, 53 patients who had failed sunitinib therapy were given once-daily doses of 0.25mg/kg.
Navigating Cancer surveyed 326 cancer caregivers through an online survey in October 2010. We defined a cancer caregiver as someone who provides unpaid assistance such as personal care, help with medications and other treatments, transportation to doctors appointments and arranging services. The survey results revealed significant emotional, financial and physical strain on the cancer caregiver community, as well as a lack of comprehensive resources to support their needs.
443,000 people die each year in the USA as a result of tobacco use - the leading cause of preventable and premature death in the country. 1,200 people each day lose their lives because they smoke or used to smoke regularly.
|Powered by NeonCRM|